J. Goldman & Co’s Nuvalent NUVL Stock Holding History

J. Goldman & Co’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,400	Closed	-$1.6M	–	581
2024 Q4	$1.6M	Buy	+20,400	New	+$1.91M	0.04%	293

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J. Goldman & Co's NUVL Position: Q4 2025 in Review

J. Goldman & Co sold out of Nuvalent (NUVL) in Q4 2025, closing a stake of 2,936 shares — an estimated $254K sold.

J. Goldman & Co first reported a position in NUVL in Q1 2024 and held it in 6 quarters. The position peaked at $1.81M in Q4 2024. 237 funds tracked by Wall St. Rank hold NUVL as of Q4 2025.

J. Goldman & Co reported no remaining Nuvalent position as of Q4 2025 after selling out during the quarter.
J. Goldman & Co sold 2,936 Nuvalent shares in Q4 2025, an estimated $254K.
J. Goldman & Co first reported a position in Nuvalent in Q1 2024 and held it in 6 quarters.
J. Goldman & Co's Nuvalent position peaked at $1.81M in Q4 2024.
237 funds tracked by Wall St. Rank held Nuvalent as of Q4 2025.

Based on J. Goldman & Co's 13F filing for Q4 2025, filed 17 Feb 2026.